Serveur d'exploration sur les pandémies grippales - Exploration (Accueil)

Index « MeshFr.i » - entrée « Vaccins inactivés »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccins conjugués < Vaccins inactivés < Vaccins sous-unitaires  Facettes :

List of bibliographic references indexed by Vaccins inactivés

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]
Ident.Authors (with country if any)Title
000384 (2019) Punnee Pitisuttithum [Thaïlande] ; Ponthip Wirachwong [Thaïlande]A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand
000637 (2017) Yoshio Hirota [Japon] ; Kotaro Ozasa [Japon] ; Takashi Nakano [Japon]Vaccine epidemiology: Its role in promoting sound immunization programs in Japan.
000666 (2017) Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro SakodaPotency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice
000691 (2017) Xin Li ; Houbin Ju ; Jian Liu ; Dequan Yang ; Xinyong Qi ; Xianchao Yang ; Yafeng Qiu ; Jie Zheng ; Feifei Ge ; Jinping ZhouInfluenza virus‐like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken
000708 (2017) Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
000737 (2017) Tülin Morç L [États-Unis] ; Brett L. Hurst [États-Unis] ; E. Bart Tarbet [États-Unis]Calcium Phosphate Nanoparticle (CaPNP) for Dose-Sparing of Inactivated Whole Virus Pandemic Influenza A (H1N1) 2009 Vaccine in Mice
000882 (2016) David L. Gordon [Australie] ; Dimitar Sajkov [Australie] ; Yoshikazu Honda-Okubo [Australie] ; Samuel H. Wilks [Royaume-Uni] ; Malet Aban [Australie] ; Ian G. Barr [Australie] ; Nikolai Petrovsky [Australie]Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
000885 (2016) Leora R. Feldstein [États-Unis] ; Laura Matrajt [États-Unis] ; M. Elizabeth Halloran [États-Unis] ; Wendy A. Keitel [États-Unis] ; Ira M. Longini [États-Unis]Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies
000912 (2016) Nuriban Valero-Pacheco [Mexique] ; Marisol Pérez-Toledo [Mexique] ; Miguel Ngel Villasís-Keever [Mexique] ; Adriana Nú Ez-Valencia [Mexique] ; Ilka Bosc Gárate [Mexique] ; Bernardo Lozano-Dubernard [Mexique] ; Horacio Lara-Puente [Mexique] ; Clara Espitia [Mexique] ; Celia Alpuche-Aranda [Mexique] ; Laura C. Bonifaz [Mexique] ; Lourdes Arriaga-Pizano [Mexique] ; Rodolfo Pastelin-Palacios [Mexique] ; Armando Isibasi [Mexique] ; Constantino L Pez-Macías [Mexique, Royaume-Uni]Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine
000B93 (2015) Tao Qin ; Yinyan Yin ; Qinghua Yu ; Lulu Huang ; Xiaoqing Wang ; Jian Lin ; Qian YangCpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa
000C12 (2015) Yoshikazu Honda-Okubo [Australie] ; Chun Hao Ong [Australie] ; Nikolai Petrovsky [Australie]Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
000E11 (2014) Duc-Huy Chu [Japon] ; Yoshihiro Sakoda [Japon] ; Tatsuya Nishi [Japon] ; Takahiro Hiono [Japon] ; Shintaro Shichinohe [Japon] ; Masatoshi Okamatsu [Japon] ; Hiroshi Kida [Japon]Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).
000E12 (2014) Tatsuya Nishi [Japon] ; Yoshihiro Sakoda ; Masatoshi Okamatsu ; Hiroshi KidaPotency of an inactivated influenza vaccine prepared from A/duck/Hong Kong/960/1980 (H6N2) against a challenge with A/duck/Vietnam/OIE-0033/2012 (H6N2) in mice.
000E53 (2014) Surender Khurana [États-Unis] ; Elizabeth M. Coyle [États-Unis] ; Swati Verma [États-Unis] ; Lisa R. King [États-Unis] ; Jody Manischewitz [États-Unis] ; Corey J. Crevar [États-Unis] ; Donald M. Carter [États-Unis] ; Ted M. Ross [États-Unis] ; Hana Golding [États-Unis]H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
000E90 (2014) Manjusha Gaglani ; Sarah Spencer ; Sarah Ball ; Juhee Song ; Allison Naleway ; Emily Henkle ; Sam Bozeman ; Sue Reynolds ; Wendy Sessions ; Kathy Hancock ; Mark ThompsonAntibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.
001299 (2013) Gregory A. Poland [États-Unis] ; Douglas M. Fleming ; John J. Treanor ; Eugene Maraskovsky ; Thomas C. Luke ; Emma M A. Ball ; Caroline M. PolandNew Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
001377 (2013) Yeu-Chun Kim [Corée du Sud] ; Dae-Goon Yoo [États-Unis] ; Richard W. Compans [États-Unis] ; Sang-Moo Kang [États-Unis] ; Mark R. Prausnitz [États-Unis]Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles
001580 (2013) Fenghua Zhang [République populaire de Chine] ; Fang Fang [République populaire de Chine, Niger] ; Haiyan Chang [République populaire de Chine] ; Bo Peng [République populaire de Chine] ; Jian Wu [République populaire de Chine] ; Jianjun Chen [République populaire de Chine] ; Hanzhong Wang [République populaire de Chine] ; Ze Chen [République populaire de Chine]Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine
001A24 (2012) Flor M. Munoz [États-Unis]Safety of influenza vaccines in pregnant women.
001B65 (2012) David W. Scheifele [Canada] ; Brian J. Ward ; Marc Dionne ; Otto G. Vanderkooi ; Mark Loeb ; Brenda L. Coleman ; Yan LiCompatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: results of a randomized, controlled trial.
001B97 (2012) Greg L. Plosker [Nouvelle-Zélande]A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Vaccins inactivés" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Vaccins inactivés" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Vaccins inactivés
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021